Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Faculty Disclosure
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationship(s), which have been resolved through an established COI resolution process, and have stated that these reported relationship(s) will not have any impact on their ability to give an unbiased presentation.

Donna Rice, MBA, BSN, RN, CDE
Consulting fees/advisory boards: Metabolic Pulse, Eli Lilly & Company, AgaMatrix, Inc
Speakers Bureau: Pfizer, Inc

Howard Baum, MD
Consulting fees/advisory boards: Novo Nordisk Pharmaceutical Industries, Inc.

Zachary T. Bloomgarden, MD
Consulting fees/advisory boards: Takeda Pharmaceuticals North America, Novo Nordisk Pharmaceutical Industries, Inc.
Fees received for promotional/non-CME activities: Eli Lilly and Company, Merck & Co., Inc., Daiichi Sankyo, Inc.
Ownership interest: Novartis Pharmaceuticals

John B. Buse, MD, PhD
Ownership interest (stocks/stock options, excluding mutual funds): Insulet Corporation

Steven V. Edelman, MD
Consulting fees/advisory boards: Eli Lilly and Company, sanofi-aventis U.S., Novo Nordisk Pharmaceutical Industries, Inc., Amylin
Fees received for promotional/non-CME activities: Eli Lilly and Company, sanofi-aventis U.S., Novo Nordisk Pharmaceutical Industries, Inc., Amylin

Francine R. Kaufman, MD
Membership on an advisory panel, standing committee, or board of directors: Eli Lilly and Company, Novo Nordisk Pharmaceutical Industries, Inc., Medtronic MiniMed, Insulet Corporation, Clinical Products, Inc., LifeScan, Inc., Amylin, Johnson & Johnson, Abbott Diabetes Care, Mannkind, Kinexum/INGAP, Nestle, dLife, Health Management Corporation
Grant and research support: Medtronic Minimed, Novo Nordisk Pharmaceutical Industries, Inc., Bristol-Myers Squibb, Merck & Co., Inc.
Stock: Clinical Products, Inc., Amylin, MannKind

Louis Kuritzky, MD (Planner)
Consulting fees/advisory boards: Eli Lilly and Company, Novo Nordisk Pharmaceutical Industries, Inc.
Fees received for promotional/non-CME activities: Eli Lilly and Company, sanofi-aventis U.S.

Frank Lavernia, MD
Consulting fees/advisory boards: sanofi-aventis U.S.

John Leahy, MD
Consulting Fees, (e.g. advisory boards) Merck & Co., Inc., sanofi-aventis U.S., Takeda Pharmaceuticals North America Fees received for promotional/non-CME activities: Merck & Co.

James Nuckolls, MD (Reviewer)
Consulting fees/advisory boards: Novartis Pharmaceuticals, Eli Lilly and Company

John Gerich, MD
Consulting fees/advisory boards: Amylin, Centocor, Inc., Eisai Inc., Elixir Pharmaceuticals, Inc., GlaxoSmithKline, Johnson & Johnson, Kowa, Lifescan, Merck & Co., Inc., Novartis Pharmaceuticals, Novo Nordisk Pharmaceutical Industries, Inc., Pfizer, Inc., Daiichi Sankyo, Inc., sanofi-aventis U.S., Sirtris Pharmaceuticals, Inc.
Speaker's Bureau: GlaxoSmithKline, Lifescan, Merck & Co., Inc., Novartis Pharmaceuticals, Novo Nordisk Pharmaceutical Industries, Inc., Pfizer, Inc., sanofi-aventis U.S.
Grants/Clinical Trials: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, GlaxoSmithKline, Kowa, Novartis Pharmaceuticals, Novo Nordisk Pharmaceutical Industries, Inc., Pfizer, Inc. Daiichi Sankyo, Inc., sanofi-aventis U.S., Takeda Pharmaceuticals North America Stephen Davis, MD, FRCP Contracted Research: Bayer Health Care, Eli Lilly & Company, sanofi-aventis, U.S., King Pharmaceuticals, Inc.

Michael L. Santiago, MD and the other employees of Med-IQ have no financial relationships to disclose.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Med-IQ designates this activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Endorsed by

Evidence-Based Content Statement
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Acknowledgment of Commercial Support
This series is supported by an educational grant from sanofi-aventis U.S.

Medium and Method of Participation/Instructions to Receive Credit
This CME activity consists of 3 stages. To receive credit, each participant must read the introductory CME material, complete all 3 stages, and complete the corresponding attestation and evaluation.

Copyright
© 2009 Med-IQ. All rights reserved.